Translating the combination of TGFβ blockade and radiotherapy into clinical development in glioblastoma

10Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

To improve multimodal glioblastoma treatment strategies, it appears useful to integrate a selective inhibitor of the tβr-I kinase, which may be able to potentiate radiation responses by increasing apoptosis and cancer-stem-like cell targeting while blockingDNA damage repair, invasion, mesenchymal transition and angiogenesis. © 2012 Landes Bioscience.

Cite

CITATION STYLE

APA

Zhang, M., Lahn, M., & Huber, P. E. (2012). Translating the combination of TGFβ blockade and radiotherapy into clinical development in glioblastoma. OncoImmunology, 1(6), 943–945. https://doi.org/10.4161/onci.19789

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free